Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

LPA Receptor 4 deficiency attenuates experimental atherosclerosis.

Yang L, Kraemer M, Fang XF, Angel PM, Drake RR, Morris AJ, Smyth SS.

J Lipid Res. 2019 Feb 22. pii: jlr.M091066. doi: 10.1194/jlr.M091066. [Epub ahead of print]

2.

The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.

Staal B, Liu Y, Barnett D, Hsueh P, He Z, Gao C, Partyka K, Hurd MW, Singhi AD, Drake RR, Huang Y, Maitra A, Brand RE, Haab BB.

Clin Cancer Res. 2019 Jan 7. doi: 10.1158/1078-0432.CCR-18-3310. [Epub ahead of print]

PMID:
30617132
3.

Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues.

Scott DA, Casadonte R, Cardinali B, Spruill L, Mehta AS, Carli F, Simone N, Kriegsmann M, Del Mastro L, Kriegsmann J, Drake RR.

Proteomics Clin Appl. 2019 Jan;13(1):e1800014. doi: 10.1002/prca.201800014.

PMID:
30592377
4.

MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues.

Drake RR, West CA, Mehta AS, Angel PM.

Adv Exp Med Biol. 2018;1104:59-76. doi: 10.1007/978-981-13-2158-0_4.

PMID:
30484244
5.

Diet Supplementation with Soy Protein Isolate, but Not the Isoflavone Genistein, Protects Against Alcohol-Induced Tumor Progression in DEN-Treated Male Mice.

Mercer KE, Pulliam CF, Hennings L, Cleves MA, Jones EE, Drake RR, Ronis MJJ.

Adv Exp Med Biol. 2018;1032:115-126. doi: 10.1007/978-3-319-98788-0_9.

6.

Extracellular Matrix Imaging of Breast Tissue Pathologies by MALDI-Imaging Mass Spectrometry.

Angel PM, Schwamborn K, Comte-Walters S, Clift CL, Ball LE, Mehta AS, Drake RR.

Proteomics Clin Appl. 2019 Jan;13(1):e1700152. doi: 10.1002/prca.201700152. Epub 2018 Dec 14.

PMID:
30251340
7.

In Situ Imaging of Tryptic Peptides by MALDI Imaging Mass Spectrometry Using Fresh-Frozen or Formalin-Fixed, Paraffin-Embedded Tissue.

Angel PM, Norris-Caneda K, Drake RR.

Curr Protoc Protein Sci. 2018 Nov;94(1):e65. doi: 10.1002/cpps.65. Epub 2018 Aug 16.

PMID:
30114342
8.

N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.

West CA, Wang M, Herrera H, Liang H, Black A, Angel PM, Drake RR, Mehta AS.

J Proteome Res. 2018 Oct 5;17(10):3454-3462. doi: 10.1021/acs.jproteome.8b00323. Epub 2018 Sep 5.

PMID:
30110170
9.

In Situ Imaging of N-Glycans by MALDI Imaging Mass Spectrometry of Fresh or Formalin-Fixed Paraffin-Embedded Tissue.

Drake RR, Powers TW, Norris-Caneda K, Mehta AS, Angel PM.

Curr Protoc Protein Sci. 2018 Nov;94(1):e68. doi: 10.1002/cpps.68. Epub 2018 Aug 3.

PMID:
30074304
10.

Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular Pathology.

McDonald WS, Jones EE, Wojciak JM, Drake RR, Sabbadini RA, Harris NG.

Am J Pathol. 2018 Aug;188(8):1779-1793. doi: 10.1016/j.ajpath.2018.05.005. Epub 2018 Jul 16.

PMID:
30037420
11.

C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.

Mulligan JK, Patel K, Williamson T, Reaves N, Carroll W, Stephenson SE, Gao P, Drake RR, Neely BA, Tomlinson S, Schlosser RJ, Atkinson C.

Mucosal Immunol. 2018 Sep;11(5):1375-1385. doi: 10.1038/s41385-018-0048-x. Epub 2018 Jun 15.

12.

Mapping Extracellular Matrix Proteins in Formalin-Fixed, Paraffin-Embedded Tissues by MALDI Imaging Mass Spectrometry.

Angel PM, Comte-Walters S, Ball LE, Talbot K, Mehta A, Brockbank KGM, Drake RR.

J Proteome Res. 2018 Jan 5;17(1):635-646. doi: 10.1021/acs.jproteome.7b00713. Epub 2017 Dec 11.

PMID:
29161047
13.

MALDI Imaging Mass Spectrometry of N-glycans and Tryptic Peptides from the Same Formalin-Fixed, Paraffin-Embedded Tissue Section.

Angel PM, Mehta A, Norris-Caneda K, Drake RR.

Methods Mol Biol. 2018;1788:225-241. doi: 10.1007/7651_2017_81.

14.

Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS/MS and High-Resolution MALDI Imaging Mass Spectrometry.

Jones EE, Zhang W, Zhao X, Quiason C, Dale S, Shahidi-Latham S, Grabowski GA, Setchell KDR, Drake RR, Sun Y.

SLAS Discov. 2017 Dec;22(10):1218-1228. doi: 10.1177/2472555217719372. Epub 2017 Jul 17.

PMID:
28714776
15.

The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells.

Barnett D, Liu Y, Partyka K, Huang Y, Tang H, Hostetter G, Brand RE, Singhi AD, Drake RR, Haab BB.

Sci Rep. 2017 Jun 22;7(1):4020. doi: 10.1038/s41598-017-04164-z.

16.

Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.

Sikora J, Dworski S, Jones EE, Kamani MA, Micsenyi MC, Sawada T, Le Faouder P, Bertrand-Michel J, Dupuy A, Dunn CK, Xuan ICY, Casas J, Fabrias G, Hampson DR, Levade T, Drake RR, Medin JA, Walkley SU.

Am J Pathol. 2017 Apr;187(4):864-883. doi: 10.1016/j.ajpath.2016.12.005.

17.

Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve.

Angel PM, Baldwin HS, Gottlieb Sen D, Su YR, Mayer JE, Bichell D, Drake RR.

Biochim Biophys Acta Proteins Proteom. 2017 Jul;1865(7):927-935. doi: 10.1016/j.bbapap.2017.03.009. Epub 2017 Mar 21. Review.

18.

Preface.

Drake RR, McDonnell LA.

Adv Cancer Res. 2017;134:xiii-xiv. doi: 10.1016/S0065-230X(17)30008-8. No abstract available.

PMID:
28110658
19.

MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.

Drake RR, Powers TW, Jones EE, Bruner E, Mehta AS, Angel PM.

Adv Cancer Res. 2017;134:85-116. doi: 10.1016/bs.acr.2016.11.009. Epub 2016 Dec 20. Review.

20.

Mass Spectrometry Imaging in Cancer Research: Future Perspectives.

McDonnell LA, Angel PM, Lou S, Drake RR.

Adv Cancer Res. 2017;134:283-290. doi: 10.1016/bs.acr.2016.11.010. Epub 2016 Dec 30. Review.

PMID:
28110655
21.

Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.

Shao S, Neely BA, Kao TC, Eckhaus J, Bourgeois J, Brooks J, Jones EE, Drake RR, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):711-718. doi: 10.1158/1055-9965.EPI-16-0732. Epub 2016 Dec 21.

22.

Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section.

Heijs B, Holst S, Briaire-de Bruijn IH, van Pelt GW, de Ru AH, van Veelen PA, Drake RR, Mehta AS, Mesker WE, Tollenaar RA, Bovée JV, Wuhrer M, McDonnell LA.

Anal Chem. 2016 Aug 2;88(15):7745-53. doi: 10.1021/acs.analchem.6b01739. Epub 2016 Jul 14.

PMID:
27373711
23.

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.

Kim Y, Jeon J, Mejia S, Yao CQ, Ignatchenko V, Nyalwidhe JO, Gramolini AO, Lance RS, Troyer DA, Drake RR, Boutros PC, Semmes OJ, Kislinger T.

Nat Commun. 2016 Jun 28;7:11906. doi: 10.1038/ncomms11906.

24.

Linkage-Specific in Situ Sialic Acid Derivatization for N-Glycan Mass Spectrometry Imaging of Formalin-Fixed Paraffin-Embedded Tissues.

Holst S, Heijs B, de Haan N, van Zeijl RJ, Briaire-de Bruijn IH, van Pelt GW, Mehta AS, Angel PM, Mesker WE, Tollenaar RA, Drake RR, Bovée JV, McDonnell LA, Wuhrer M.

Anal Chem. 2016 Jun 7;88(11):5904-13. doi: 10.1021/acs.analchem.6b00819. Epub 2016 May 23.

PMID:
27145236
25.

Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.

Neely BA, Wilkins CE, Marlow LA, Malyarenko D, Kim Y, Ignatchenko A, Sasinowska H, Sasinowski M, Nyalwidhe JO, Kislinger T, Copland JA, Drake RR.

PLoS One. 2016 Apr 29;11(4):e0154074. doi: 10.1371/journal.pone.0154074. eCollection 2016.

26.

Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male Mice.

Mercer KE, Pulliam C, Hennings L, Lai K, Cleves M, Jones E, Drake RR, Ronis M.

Cancer Prev Res (Phila). 2016 Jun;9(6):466-75. doi: 10.1158/1940-6207.CAPR-15-0417. Epub 2016 Mar 22.

27.

FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.

Sundararaj KP, Thiyagarajan T, Molano I, Basher F, Powers TW, Drake RR, Nowling TK.

J Immunol. 2015 Dec 15;195(12):5551-60. doi: 10.4049/jimmunol.1500961. Epub 2015 Nov 4.

28.

Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow.

Jones EE, Gao P, Smith CD, Norris JS, Drake RR.

Bioanalysis. 2015;7(20):2611-9. doi: 10.4155/bio.15.174. Epub 2015 Oct 27.

PMID:
26505686
29.

Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.

Powers TW, Holst S, Wuhrer M, Mehta AS, Drake RR.

Biomolecules. 2015 Oct 15;5(4):2554-72. doi: 10.3390/biom5042554.

30.

Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.

Yang L, Dutta SM, Troyer DA, Lin JB, Lance RA, Nyalwidhe JO, Drake RR, Semmes OJ.

Oncotarget. 2015 Dec 22;6(41):43743-58. doi: 10.18632/oncotarget.6193.

31.

The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.

Venant H, Rahmaniyan M, Jones EE, Lu P, Lilly MB, Garrett-Mayer E, Drake RR, Kraveka JM, Smith CD, Voelkel-Johnson C.

Mol Cancer Ther. 2015 Dec;14(12):2744-52. doi: 10.1158/1535-7163.MCT-15-0279. Epub 2015 Oct 22.

32.

A2E and lipofuscin distributions in macaque retinal pigment epithelium are similar to human.

Pallitto P, Ablonczy Z, Jones EE, Drake RR, Koutalos Y, Crouch RK, Donello J, Herrmann J.

Photochem Photobiol Sci. 2015 Oct;14(10):1888-95. doi: 10.1039/c5pp00170f.

33.

College student mental health and quality of workplace relationships.

Vaughn AA, Drake RR Jr, Haydock S.

J Am Coll Health. 2016;64(1):26-37. doi: 10.1080/07448481.2015.1064126.

PMID:
26151646
34.

Unique to this volume is the subsequent focus of individual chapters on what is known about glycosylation in relation to specific organ sites of cancer. Preface.

Drake RR, Ball L.

Adv Cancer Res. 2015;126:xiii-xiv. doi: 10.1016/S0065-230X(15)00022-6. No abstract available.

PMID:
25727154
35.

Altered glycosylation in prostate cancer.

Drake RR, Jones EE, Powers TW, Nyalwidhe JO.

Adv Cancer Res. 2015;126:345-82. doi: 10.1016/bs.acr.2014.12.001. Epub 2015 Feb 7. Review.

PMID:
25727153
36.

Glycosylation and cancer: moving glycomics to the forefront.

Drake RR.

Adv Cancer Res. 2015;126:1-10. doi: 10.1016/bs.acr.2014.12.002. Epub 2015 Feb 7. Review.

PMID:
25727144
37.

Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis.

Rachidi S, Sun S, Wu BX, Jones E, Drake RR, Ogretmen B, Cowart LA, Clarke CJ, Hannun YA, Chiosis G, Liu B, Li Z.

J Hepatol. 2015 Apr;62(4):879-88. doi: 10.1016/j.jhep.2014.11.010. Epub 2014 Nov 22.

38.

Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.

Nowling TK, Mather AR, Thiyagarajan T, Hernández-Corbacho MJ, Powers TW, Jones EE, Snider AJ, Oates JC, Drake RR, Siskind LJ.

J Am Soc Nephrol. 2015 Jun;26(6):1402-13. doi: 10.1681/ASN.2014050508. Epub 2014 Sep 30.

39.

Glutathione S-transferase P influences redox and migration pathways in bone marrow.

Zhang J, Ye ZW, Gao P, Reyes L, Jones EE, Branham-O'Connor M, Blumer JB, Drake RR, Manevich Y, Townsend DM, Tew KD.

PLoS One. 2014 Sep 12;9(9):e107478. doi: 10.1371/journal.pone.0107478. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0119266.

40.

MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays.

Powers TW, Neely BA, Shao Y, Tang H, Troyer DA, Mehta AS, Haab BB, Drake RR.

PLoS One. 2014 Sep 3;9(9):e106255. doi: 10.1371/journal.pone.0106255. eCollection 2014.

41.

On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging.

Jones EE, Dworski S, Canals D, Casas J, Fabrias G, Schoenling D, Levade T, Denlinger C, Hannun YA, Medin JA, Drake RR.

Anal Chem. 2014 Aug 19;86(16):8303-11. doi: 10.1021/ac501937d. Epub 2014 Aug 8.

42.

Cryopreservation of viable human lung tissue for versatile post-thaw analyses and culture.

Baatz JE, Newton DA, Riemer EC, Denlinger CE, Jones EE, Drake RR, Spyropoulos DD.

In Vivo. 2014 Jul-Aug;28(4):411-23.

43.

The proteomics of prostate cancer exosomes.

Drake RR, Kislinger T.

Expert Rev Proteomics. 2014 Apr;11(2):167-77. doi: 10.1586/14789450.2014.890894. Epub 2014 Feb 25.

PMID:
24564711
44.

MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.

Jones EE, Powers TW, Neely BA, Cazares LH, Troyer DA, Parker AS, Drake RR.

Proteomics. 2014 Apr;14(7-8):924-35. doi: 10.1002/pmic.201300434. Epub 2014 Mar 3.

45.

Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Cheng JC, Bai A, Beckham TH, Marrison ST, Yount CL, Young K, Lu P, Bartlett AM, Wu BX, Keane BJ, Armeson KE, Marshall DT, Keane TE, Smith MT, Jones EE, Drake RR Jr, Bielawska A, Norris JS, Liu X.

J Clin Invest. 2013 Oct;123(10):4344-58. doi: 10.1172/JCI64791. Epub 2013 Sep 16.

46.

Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues.

Powers TW, Jones EE, Betesh LR, Romano PR, Gao P, Copland JA, Mehta AS, Drake RR.

Anal Chem. 2013 Oct 15;85(20):9799-806. doi: 10.1021/ac402108x. Epub 2013 Oct 3.

47.

Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.

Nyalwidhe JO, Betesh LR, Powers TW, Jones EE, White KY, Burch TC, Brooks J, Watson MT, Lance RS, Troyer DA, Semmes OJ, Mehta A, Drake RR.

Proteomics Clin Appl. 2013 Oct;7(9-10):677-89. doi: 10.1002/prca.201200134. Epub 2013 Sep 13.

48.

Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012.

Leymarie N, Griffin PJ, Jonscher K, Kolarich D, Orlando R, McComb M, Zaia J, Aguilan J, Alley WR, Altmann F, Ball LE, Basumallick L, Bazemore-Walker CR, Behnken H, Blank MA, Brown KJ, Bunz SC, Cairo CW, Cipollo JF, Daneshfar R, Desaire H, Drake RR, Go EP, Goldman R, Gruber C, Halim A, Hathout Y, Hensbergen PJ, Horn DM, Hurum D, Jabs W, Larson G, Ly M, Mann BF, Marx K, Mechref Y, Meyer B, Möginger U, Neusüβ C, Nilsson J, Novotny MV, Nyalwidhe JO, Packer NH, Pompach P, Reiz B, Resemann A, Rohrer JS, Ruthenbeck A, Sanda M, Schulz JM, Schweiger-Hufnagel U, Sihlbom C, Song E, Staples GO, Suckau D, Tang H, Thaysen-Andersen M, Viner RI, An Y, Valmu L, Wada Y, Watson M, Windwarder M, Whittal R, Wuhrer M, Zhu Y, Zou C.

Mol Cell Proteomics. 2013 Oct;12(10):2935-51. doi: 10.1074/mcp.M113.030643. Epub 2013 Jun 13.

49.

Targeted glycoprotein enrichment and identification in stromal cell secretomes using azido sugar metabolic labeling.

Roper SM, Zemskova M, Neely BA, Martin A, Gao P, Jones EE, Kraft AS, Drake RR.

Proteomics Clin Appl. 2013 Jun;7(5-6):367-71. doi: 10.1002/prca.201300006.

50.

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, Brooks J, Semmes OJ, Troyer DA, Lance RS, Kislinger T, Drake RR.

Proteomics. 2013 May;13(10-11):1667-1671. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.

Supplemental Content

Loading ...
Support Center